CRL

Charles River Laboratories International Inc
$326.99-$24.88-7.07%Price as of Nov 4, 2026, 5:30 PM ET

Key stats

Market cap
15.6B
Open
—
Day range
—
52-week range
$146.20 – $379.63
Volume
1.52M
Avg volume
1.24M

Earnings

Q3 FY26Beat
Expected$3.00
Actual$3.09
Q2 FY26
Actual$-0.03
Q1 FY26
Actual$-0.30
Q4 FY25
Actual$-5.68

Next earnings call Feb 17, 2027

About

Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provide in vitro (nonanimal) testing products, biologics testing services, and avian vaccine services.

Employees
19,700
Headquarters
Wilmington, MA